Olaparib, may help to improve duration of good quality of life and quality-adjusted progression-free survival in germline BRCA1/2-mutated ovarian cancer.
Overall response of platelet count 50,000/L seen in 43% of patients.
As fecal microbiota transplantation has been found to be effective in treating a number of gastrointestinal diseases, such as Clostridium difficile infection, researchers are now assessing whether it may also be effective for patients with irritable bowel syndrome.
Transcranial magnetic stimulation (TMS) uses magnetic fields to stimulate nerve cells in the brain.
Lower degree of susceptibility to ibalizumab for 9 of 10 patients with virology failure, rebound.
A systematic literature review, published in Clinical Infectious Diseases, found no evidence supporting a benefit to antibacterial therapy for osteomyelitis in patients with stage IV sacral pressure ulcers.
Oral administration of BCX7353 at dose of 125 mg results in lower rate of attacks vs placebo.
Rifampin has significantly higher rate of treatment completion, fewer drug-related adverse events.
For patients with moderate to severe atopic dermatitis inadequately controlled with topical therapies, the anti-IL-31 receptor A humanized monoclonal antibody nemolizumab may provide benefit.
ART recommended for almost all HIV-infected; should be initiated as soon as possible post diagnosis.
